Federation des caisses Desjardins du Quebec’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Hold	0	–	-$77	–	2343
2019 Q1	–	Hold	0	–	–	–	2050
2018 Q4	–	Hold	0	–	–	–	2042
2018 Q3	–	Hold	0	–	–	–	1706
2018 Q2	–	Hold	0	–	–	–	1661
2018 Q1	–	Hold	0	–	–	–	1625
2017 Q4	–	Hold	0	–	–	–	2034
2017 Q3	–	Hold	0	–	–	–	1986
2017 Q2	–	Hold	0	–	–	–	2065
2017 Q1	–	Hold	0	–	–	–	1673

Other funds holding SEEL

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Piper Sandler & Co Minneapolis, Minnesota $135M AUM 0.15% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return